Citation Impact
Citing Papers
Immunological aspects of cancer chemotherapy
2007
ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model
2023 StandoutNobel
Effect of biliary obstruction on 26-hydroxylation of C27-steroids in bile acid synthesis
1978
Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype
2018
Tumor angiogenesis: causes, consequences, challenges and opportunities
2019
Mechanism of degradation of the steroid side chain in the formation of bile acids.
1992
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
2005 Standout
Lipid nanoparticles for mRNA delivery
2021 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
2012
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Multiparametric Analysis of Cell-Free DNA in Melanoma Patients
2012
Macrophages in immunoregulation and therapeutics
2023 Standout
Systematic Review of Complications of Prostate Biopsy
2013
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Cancer immunotherapy via dendritic cells
2012 Standout
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
Side Chain Hydroxylations in Bile Acid Biosynthesis Catalyzed by CYP3A Are Markedly Up-regulated in Cyp27 Mice but Not in Cerebrotendinous Xanthomatosis
2001
DIANA-mirExTra v2.0: Uncovering microRNAs and transcription factors with crucial roles in NGS expression data
2016
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
The anticancer immune response: indispensable for therapeutic success?
2008
Delivery technologies for cancer immunotherapy
2019 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5β-cholestane-3α,7α,12α-triol in human liver microsomes
1999
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
RNA-Based Tools for Nuclear Reprogramming and Lineage-Conversion: Towards Clinical Applications
2013
mRNA transcript therapy
2014 StandoutNobel
PROTAC targeted protein degraders: the past is prologue
2022 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis
2011
Human-on-chip for therapy development and fundamental science
2013
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Berberine acts as a putative epigenetic modulator by affecting the histone code
2016
Origins, structures, and functions of circulating DNA in oncology
2016
7β-hydroxy bile alcohols: Facile synthesis and 2D 1H NMR studies of 5β-cholestane-3α,7β,12α,25-tetrol
1997
Atherosclerosis
2001 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review
2017
Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery
2022 StandoutNobel
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
2009 Standout
Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids.
1987
Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
2021
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
2011 Standout
Exquisitely Specific anti-KRAS Biodegraders Inform on the Cellular Prevalence of Nucleotide-Loaded States
2020
Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety
2021
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Radioligand Therapy With 177Lu-PSMA for Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
2019
Organogenesis in a dish: Modeling development and disease using organoid technologies
2014 StandoutScience
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Advances in Cancer Immunotherapy in Solid Tumors
2016
Therapeutic Responses and Survival Effects of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castrate-Resistant Prostate Cancer
2018
A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma
2016
On the stereospecificity of microsomal “26”-hydroxylation in bile acid biosynthesis.
1978
Ribozyme Assays to Quantify the Capping Efficiency of In Vitro-Transcribed mRNA
2022 StandoutNobel
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Microwave assisted organic synthesis—a review
2001 Standout
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Nanoplatforms for mRNA Therapeutics
2020
Azithromycin Polarizes Macrophages to an M2 Phenotype via Inhibition of the STAT1 and NF-κB Signaling Pathways
2019
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Stefan Hauser being referenced
mRNA as a Novel Treatment Strategy for Hereditary Spastic Paraplegia Type 5
2019
Apelin and apelin receptor expression in renal cell carcinoma
2019
Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617
2017
Interleukin-2/interferon-α2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
2006
Urological surgery in patients with hemorrhagic bleeding disorders Hemophilia A, Hemophilia B, von Willebrand disease: a retrospective study with matched pairs analysis
2012
Circulating mitochondrial DNA in serum: A universal diagnostic biomarker for patients with urological malignancies
2010
Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617
2016
Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma
2011
Thulium Laser (Revolix) Vapoenucleation of the Prostate Is a Safe Procedure in Patients with an Increased Risk of Hemorrhage
2012
1,8-Cineol inhibits nuclear translocation of NF-κB p65 and NF-κB-dependent transcriptional activity
2013
MicroRNAs in pluripotency, reprogramming and cell fate induction
2013
Rapamycin Inhibits In Vitro Growth and Release of Angiogenetic Factors in Human Bladder Cancer
2008
Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma
2010
Cell-free circulating DNA: Diagnostic value in patients with renal cell cancer.
2010
Serum DNA hypermethylation in patients with bladder cancer: results of a prospective multicenter study.
2013
A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat.
1976
Long-term survival of patients with metastatic renal cell carcinoma treated with pulsed dendritic cells.
2010